Skip to main content
HR 1220 113th Congress House

Asthma Inhalers Relief Act of 2013

Official title: To direct the Administrator of the Environmental Protection Agency to allow for the distribution, sale, and consumption in the United States of remaining inven… Show full official titleShow less

Official title: To direct the Administrator of the Environmental Protection Agency to allow for the distribution, sale, and consumption in the United States of remaining inventories of over-the-counter CFC epinephrine inhalers.

Introduced: March 19, 2013 See on congress.gov
Environmental Protection Administrative law and regulatory proceduresAir qualityCardiovascular and respiratory healthClimate change and greenhouse gases
More subjectsShow fewer subjects
Environmental Protection Agency (EPA)Environmental regulatory proceduresHealth technology, devices, supplies
Sign in to write a letter Sign in to watch
This bill died when the 113th Congress ended
It never became law before the 113th Congress (2013–2014) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 15, 2013
Referred to the Subcommittee on Energy and Power.
Mar 15, 2013
Referred to the House Committee on Energy and Commerce.
Mar 15, 2013
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action March 15, 2013

Referred to the Subcommittee on Energy and Power.

 Plain-English summary Congressional Research Service

Asthma Inhalers Relief Act of 2013 - Directs the Administrator of the Environmental Protection Agency (EPA) to: (1) permit the distribution, sale, and consumption in the United States of remaining inventories of CFC epinephrine inhalers manufactured pursuant to the exception for medical devices under the Clean Air Act; (2) not take any enforcement action or otherwise seek to restrict the distribution, sale, or consumption of such inhalers on the basis of any federal law implementing the Montreal Protocol on Substances that Deplete the Ozone Layer; and (3) issue, in response to a request of any distributor or seller of such inhalers, a No Action Assurance Letter stating that the EPA will not initiate an enforcement action relating to the distribution or sale of any such inhaler occurring prior to August 1, 2013.

Defines "CFC epinephrine inhaler" to mean any epinephrine inhaler containing chlorofluorocarbons that was manufactured and classified as over-the-counter before January 1, 2012.

Terminates this Act on August 1, 2013.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Cosponsors 2
All 2 Republican 1
R
Carter, John R.
Texas · Mar 19, 2013
MATHESON, JIM
· Mar 15, 2013
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 1220: Asthma Inhalers Relief Act of 2013. 113th Congress. Open America. https://openamerica.io/bill/113-HR-1220/
MLA
"H.R. 1220: Asthma Inhalers Relief Act of 2013." 113th Congress, 2026, Open America, https://openamerica.io/bill/113-HR-1220/.
Bluebook (legal)
H.R. 1220, 113th Cong. (2026), https://openamerica.io/bill/113-HR-1220/.
Markdown link
[H.R. 1220: Asthma Inhalers Relief Act of 2013](https://openamerica.io/bill/113-HR-1220/)
Report a problem